课题基金 / 基金详情

A NOVEL FAMILY OF LYMPHOCYTE ADHESION MOLECULES

A NOVEL FAMILY OF LYMPHOCYTE ADHESION MOLECULES
一个新的淋巴细胞粘附分子家族
批准号:
6310455
负责人:
PETER S. LU
金额:
$19.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-01 至 2002-01-31

项目摘要

项目成果

PETER S. LU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: T cell activation is controlled by a highly organized multi-molecular structure at the T cell-antigen presenting cell interface. This structure has recently been termed an "immunological synapse." In an effort to find novel molecules involved in this synapse, they have identified a family of five previously uncloned cadherin-like lymphocyte transmembrane proteins (the CLASP family). At least one member of the family, murine CLASP-I, is localized at the immunological synapse. The goals of phase I of this research project are to clone and sequence at least three human genes of this family and to determine their tissue expression patterns and chromosomal localization. In addition, molecules that interfere with CLASP function, such as monoclonal antibodies or recombinant soluble CLASP proteins, will be synthesized and their effect on lymphocyte activation tested in vitro. In stage II of the project, the toxicity and efficacy of these potential therapeutics will be evaluated in animal models of organ transplantation and autoimmune disease and if positive results are obtained in clinical trials in humans. Together these studies should further their molecular understanding of the immunological synapse and yield commercially viable products that, by targeting this synapse, allow improved pharmacological regulation of the immune system. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Diagnostic Assay for Oncogenic Human Papillomaviruses
  • 批准号:
    7282417
  • 项目类别:
  • 资助金额:
    $39.75万
  • 财政年份:
    2006
  • 负责人:
    PETER S. LU
  • 依托单位:
A Novel Diagnostic Assay for Oncogenic Human Papillomaviruses
  • 批准号:
    7089269
  • 项目类别:
  • 资助金额:
    $47.82万
  • 财政年份:
    2006
  • 负责人:
    PETER S. LU
  • 依托单位:
A Novel Drug To Reduce Neronal Damage Following Stroke
  • 批准号:
    6882848
  • 项目类别:
  • 资助金额:
    $19.76万
  • 财政年份:
    2004
  • 负责人:
    PETER S. LU
  • 依托单位:
Translation of a Novel Stroke Drug Administration
  • 批准号:
    7928756
  • 项目类别:
  • 资助金额:
    $85.94万
  • 财政年份:
    2004
  • 负责人:
    PETER S. LU
  • 依托单位:
国内基金
海外基金
增生性玻璃体视网膜病变早期钙黏蛋白(Cadherins)异常表达启动视网膜色素上皮细胞游离的分子机制
  • 批准号:
    81770939
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2017
  • 负责人:
    王方
  • 依托单位:
Beta-catenin/Cadherins, EphBs 在平衡颅神经嵴细胞的粘附和迁徙机制的研究
  • 批准号:
    81400494
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2014
  • 负责人:
    刘人恺
  • 依托单位:
Cadherins与nectins在青少年期慢性社会应激损害小鼠前额叶形态可塑性与功能中的作用
  • 批准号:
    81401129
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2014
  • 负责人:
    李继涛
  • 依托单位: